Summary
Carcinoma of the uterine cervix is a common malignancy among women that has been found to show loss of heterozygosity in the chromosome 11p. Recent studies have localized the TSG101 gene in this region, and also demonstrated a high frequency of abnormalities of this gene in human breast cancer. To determine the role of the TSG101 gene in the carcinogenesis of cervical and uterine carcinoma, 19 cases of cervical carcinoma and five cases of endometrial carcinoma, as well as nearby non-cancerous tissue from the same patients, and 16 blood samples from healthy persons as normal control were analysed by Southern blot analysis of genomic DNA, reverse transcription of the TSG101 mRNA followed by PCR amplification and sequencing of the products. We found that abnormal transcripts of the TSG101 gene were common both in cancerous or non-cancerous tissues of the uterus and cervix and in normal peripheral mononuclear cells. There was no genomic deletion or rearrangement in spite of the presence of abnormal transcripts, and no definite relationship between the abnormal transcripts and HPV infection was found. Although the frequency of abnormal transcripts was higher in cancerous than in non-cancerous tissue, normal peripheral mononuclear cells also had abnormal transcripts. Given these findings, the role of the TSG101 gene as a tumour-suppressor gene should be re-evaluated. Because some aberrant transcripts could be found at the first PCR reaction, we suggest that the aberrant transcripts might be the result of imperfect minor splicesome products.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Busby-Earle, R. M. C., Steel, C. M. & Bird, C. C. (1993). Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies. Br J Cancer 67: 71–75.
Chen, Y. J., Chang, J. G., Chih, L. S., Chen, P. H., Endo, M., Whang-Peng, J. & Chen, Y. M. A. (1997). Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. Int J Cancer 71: 350–354.
Chridhar, R., Sridhar, V., Wang, X., Paradee, W., Dugen, M., Sarker, F., Wike, Glover, T. W., Vaitkevicius, V. K. & Smith, D. I. (1996). Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res 56: 4347–4350.
Fujinaga, Y., Shimada, M., Okazawa, L. K., Fukushima, M., Kato, I. & Fujinagea, K. (1991). Simultaneous detection and typing of genital human papillomavirus DNA typing using the polymerase chain reaction. J Gen Virol 72: 1039–1044.
Hampton, G. M., Penny, L. A., Baergen, R. N., Larson, A., Brewen, C., Liao, S., Busby-Earle, R. M. C., Williams, A. W. R., Steel, C. M., Bird, C. C., Stanbridge, E. J. & Evans, G. A. (1994). Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22–q24. Proc Natl Acad Sci USA 91: 6953–6957.
Howley, P. M. (1991). Role of human papillomaviruses in human cancer. Cancer Res 51: (suppl.) 5019–5022.
Lee, M. P. & Feinberg, A. P. (1997). Aberrant splicing but not mutations of TSG101 in human breast cancer. Cancer Res 57: 3131–3134.
Li, L. & Cohen, S. N. (1996). TSG101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 85: 319–329.
Li, L., Li, X., Francke, U. & Cohen, S. N. (1997). The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88: 143–153.
Lin, S. Y., Chen, P. H., Wang, C. K., Liu, J. D., Siauw, C. P., Chen, Y. J., Yang, M. J., Liu, M. H., Chen, T. C. & Chang, J. G. (1993). Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method. Am J Clin Pathol 100: 686–689.
Manchall, C. J. (1991). Tumor suppressor genes. Cell 64: 313–326.
Mitra, A. B., Morty, VVVS, Li Rong, G., Mahendra, Pratop, Luthra, U. K. & Chaganti, R. S. K. (1994). Allelotype analysis of cervical carcinoma. Cancer Res 54: 4481–4487.
Murthy, N. S., Sehgal, A., Satyonarayana, L., Das, D., Singh, V., Das, B. C., Gupta, M. M., Mitra, A. B. & Luthra, U. K. (1990). Risk factors related to biological behaviour of precancerous lesions of the uterine cervix. Br J Cancer 61: 732–736.
Steiner, P., Barnes, D. M., Haris, W. H. & Weinberg, R. A. (1997). Absence of rearrangements in the tumor susceptibility gene TSG101 in human breast cancer. Nature Genet 16: 332–333.
Wahi, P. H., Mali, S. & Luthra, U. K. (1969). Factors influencing cancer of the cervix in north India. Cancer 23: 1221–1226.
Author information
Authors and Affiliations
Additional information
This study had been presented as a poster at the 47th Annual Meeting of the American Society of Human Genetics. Drs JG Chang and TH Su have made equal contributions to this study.
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Chang, JG., Su, TH., Wei, HJ. et al. Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers. Br J Cancer 79, 445–450 (1999). https://doi.org/10.1038/sj.bjc.6690069
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690069